Advisory Advocates’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DIAX
Advisory Advocates's DIAX Position: Q1 2026 in Review
Advisory Advocates sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 84,167 shares — an estimated $1.28M sold.
Advisory Advocates first reported a position in DIAX in Q4 2025 and held it in 1 quarter. The position peaked at $1.28M in Q4 2025. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.
- Advisory Advocates reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
- Advisory Advocates sold 84,167 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $1.28M.
- Advisory Advocates first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2025 and held it in 1 quarter.
- Advisory Advocates's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $1.28M in Q4 2025.
- 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.
Based on Advisory Advocates's 13F filing for Q1 2026, filed 5 May 2026.